GSM2690987 |
ATAC-seq for patient CLL10 during Ibrutinib treatment |
GSM2690988 |
ATAC-seq for patient CLL11 before Ibrutinib treatment |
GSM2690989 |
ATAC-seq for patient CLL11 during Ibrutinib treatment |
GSM2690990 |
ATAC-seq for patient CLL12 before Ibrutinib treatment |
GSM2690991 |
ATAC-seq for patient CLL12 during Ibrutinib treatment |
GSM2690992 |
ATAC-seq for patient CLL13 before Ibrutinib treatment |
GSM2690993 |
ATAC-seq for patient CLL13 during Ibrutinib treatment |
GSM2690994 |
ATAC-seq for patient CLL14 before Ibrutinib treatment |
GSM2690995 |
ATAC-seq for patient CLL14 during Ibrutinib treatment |
GSM2690996 |
ATAC-seq for patient CLL15 before Ibrutinib treatment |
GSM2690997 |
ATAC-seq for patient CLL15 during Ibrutinib treatment |
GSM2690998 |
ATAC-seq for patient CLL16 before Ibrutinib treatment |
GSM2690999 |
ATAC-seq for patient CLL16 during Ibrutinib treatment |
GSM2691000 |
ATAC-seq for patient CLL17 before Ibrutinib treatment |
GSM2691001 |
ATAC-seq for patient CLL17 during Ibrutinib treatment |
GSM2691002 |
ATAC-seq for patient CLL19 before Ibrutinib treatment |
GSM2691003 |
ATAC-seq for patient CLL19 during Ibrutinib treatment |
GSM2691004 |
ATAC-seq for patient CLL2 during Ibrutinib treatment |
GSM2691005 |
ATAC-seq for patient CLL2 before Ibrutinib treatment |
GSM2691006 |
ATAC-seq for patient CLL20 before Ibrutinib treatment |
GSM2691007 |
ATAC-seq for patient CLL20 during Ibrutinib treatment |
GSM2691008 |
ATAC-seq for patient CLL21 during Ibrutinib treatment |
GSM2691009 |
ATAC-seq for patient CLL21 before Ibrutinib treatment |
GSM2691010 |
ATAC-seq for patient CLL3 before Ibrutinib treatment |
GSM2691011 |
ATAC-seq for patient CLL3 during Ibrutinib treatment |
GSM2691012 |
ATAC-seq for patient CLL4 before Ibrutinib treatment |
GSM2691013 |
ATAC-seq for patient CLL4 during Ibrutinib treatment |
GSM2691014 |
ATAC-seq for patient CLL5 during Ibrutinib treatment |
GSM2691015 |
ATAC-seq for patient CLL5 before Ibrutinib treatment |
GSM2691016 |
ATAC-seq for patient CLL6 before Ibrutinib treatment |
GSM2691017 |
ATAC-seq for patient CLL6 during Ibrutinib treatment |
GSM2691018 |
ATAC-seq for patient CLL7 before Ibrutinib treatment |
GSM2691019 |
ATAC-seq for patient CLL7 during Ibrutinib treatment |
GSM2691020 |
ATAC-seq for patient CLL9 before Ibrutinib treatment |
GSM2691021 |
ATAC-seq for patient CLL9 during Ibrutinib treatment |